Decide what the assessment needs to tell you
Benchmarking should answer a business or operational question. You may want to understand where performance varies, whether your operating model can support growth or which improvements deserve investment.
Pharmacovigilance Benchmarking provides a structured way to examine system maturity and identify gaps. The assessment is most useful when its purpose is agreed before evidence is collected.
Step 1: Define the scope
Decide which activities, products, markets and organisational units will be assessed. Identify the period covered and any recent changes that could affect the findings.
A focused assessment may examine a particular workflow. A wider review may cover governance, quality arrangements, vendor oversight, resources and operational performance.
Step 2: Choose appropriate comparison criteria
Specify what the system will be assessed against. This may include applicable requirements, internal standards, defined maturity criteria or suitably comparable industry information.
Keep these categories distinct. A regulatory requirement and an improvement opportunity do not have the same significance. If peer data is used, confirm its source, relevance and limitations.
Step 3: Collect evidence from several sources
Combine documents and performance measures with interviews and examples of completed work.
Useful evidence may include:
- Organisation charts and responsibility records.
- Procedures and workflow descriptions.
- Performance reports and trend data.
- Issue, deviation and action records.
- Governance meeting outputs.
- Training and competency information.
Check whether the evidence reflects current practice and whether different teams use consistent definitions.
Step 4: Assess performance and maturity consistently
Apply the same criteria across the agreed scope. Record the evidence supporting each finding and identify where information is incomplete.
If performance measures differ between teams, investigate the definitions before comparing results. Where an assessment depends on current obligations, Regulatory Intelligence can help inform the assessment criteria.
Step 5: Turn findings into priorities
Separate individual observations from patterns affecting the wider system. Consider the potential consequences, causes and organisational dependencies behind each gap.
Use the results to agree which changes need immediate attention and which require longer-term planning. Pharmacovigilance Management Consulting can support the transition from assessment findings to changes in governance or delivery.
Step 6: Establish a baseline and reassessment plan
Record the starting position, agreed actions and intended outcomes. Assign owners and decide what evidence will demonstrate progress.
Benchmarking can form part of a wider Pharmacovigilance Consulting programme, with subsequent reviews checking whether improvements have strengthened the system.
Frequently Asked Questions: Benchmarking your pharmavogilance system
Start with the areas most relevant to your decision or concern. A clear, manageable scope usually produces more useful findings than an assessment that attempts to cover everything without sufficient evidence or stakeholder involvement.
Choose measures that show whether important activities are reliable, timely and appropriately controlled. Define the calculation, source and reporting period for each measure. Avoid collecting metrics simply because they are easy to produce.
Yes. You can assess performance against defined requirements, internal expectations and a transparent maturity framework. Describe the exercise accurately and avoid presenting internal targets or expert judgement as verified peer comparisons.
Consider differences in workload, complexity, product mix, responsibilities and available systems. Apply consistent definitions and explain material differences. A simple comparison of volumes or completion rates may be misleading without this context.
Record the limitation and assess how it affects confidence in the findings. Seek additional evidence where the issue is important. An absence of reliable performance information may itself identify a weakness in oversight or measurement.
Use scores to summarise a clearly defined assessment, supported by evidence and explanation. They can help track progress, but the underlying findings are more useful than the number alone. Avoid giving scores greater precision than the evidence supports.
Yes, where they help explain how processes operate. Interviews can reveal inconsistent interpretations, undocumented workarounds and practical constraints. Check interview findings against other evidence rather than relying entirely on individual recollection.
Group related findings and assess their significance, urgency and dependencies. Look for underlying weaknesses that contribute to several problems. This can produce a more effective improvement plan than treating every observation as a separate project.
Choose a review point that allows meaningful changes to take effect. Major organisational or operational changes may justify an earlier reassessment. Use consistent criteria where possible so that progress can be interpreted accurately.
Present the main risks, evidence limitations, priority actions and decisions required. Explain the resources and dependencies involved. Provide enough supporting detail for scrutiny while keeping the main report focused on what leadership needs to decide.
Understand where your pharmacovigilance system can improve
Explore Qinecsa’s Pharmacovigilance Benchmarking service to assess your current position and develop evidence-based improvement priorities.